IL6 and metabolic disease: Therefore, the reduction of inflammation by TBF treatment in diabetic mice might be due to the increased abundance of Sutterella, and it was also positively correlated with the decrease in serum IL-6, suggesting that TBF effects on microbiota might be associated with metabolic disorders.